BackSinovac Biotech, Overview

Sinovac Biotech, Other Current Assets

Latest other current assets for SVA: $690M.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$685.78M

Peer average / median

Loading

Sinovac Biotech, Other Current Assets History

Loading

Sinovac Biotech, vs. peers: Other Current Assets Comparison

Loading

Sinovac Biotech, Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Sinovac Biotech, (SVA) FAQ

Sinovac Biotech, (SVA) currently reports a other current assets of $690M as of December 2025. Use the charts on this page to explore Sinovac Biotech,'s other current assets history and peer comparisons.

Sinovac Biotech, reported $690M in other current assets as of December 2025. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current assets of $690M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Sinovac Biotech,, and consider following SVA for alerts when major investors trade the stock.

Sinovac Biotech, is classified in the Healthcare sector. On other current assets, it currently shows $690M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SVA with unrelated industries.